a) Glucagon like peptide (GLP-1 receptor agonist) b) Glucose Dependant Insuli notrophic Polypetide (GIP) GLP-1: Enhances binding to GLP-1 receptor and inhibit it from binding to DDP4 (the enzyme responsible for Incretin degredation)
Some states have begun expanding benefits for weight-related care, but in most cases, people seeking coverage for these medications may face stricter eligibility criteria or no coverage at all
However, a staggered approach might be beneficial for others, allowing healthcare providers to monitor the effects of each medication individually and adjust treatment plans as necessary
10 Medications That May Cause Increased Urination There are several potential causes of frequent urination, and the meds youre taking might be one of them
Next came a dual GLP-1/GIP receptor agonist, tirzepatide, marketed under the brand name Zepbound, which was approved for obesity in 2023